Abbott/Aventis
Transaction details
Proposal whereby Abbott Laboratories and several of its affiliates (“Abbott”) would acquire that part of the business of Aventis S.A. connected with the manufacture, distribution and sale of pharmaceutical products containing either Trandolapril or a combination of Trandolapril/Verapamil as the active ingredient (the “Proposed Transaction”).
Case details
- Notification date:4 May 2004
- Publication date:4 May 2004
- Economic sector:Manufacturing - C
- Economic sub-sector:Manufacture of pharmaceuticals - C.21
- Outcome:Cleared
Documents
M.04.028 DeterminationPDF | 205 KBM.04.028 Determination PDF | 205 KB - Opens in new window
Timetable
Parties Involved
Abbott
Multinational corporation engaged in the manufacture and supply of a broad range of healthcare products and services.
Aventis
Develops and markets pharmaceutical products.
Contacts
